ZimVie Inc.

NasdaqGS ZIMV

ZimVie Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 16.53

ZimVie Inc. Revenue Per Share is USD 16.53 for the Trailing 12 Months (TTM) ending September 30, 2024, a -50.71% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • ZimVie Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 33.54, a -7.62% change year over year.
  • ZimVie Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 36.31, a -7.94% change year over year.
  • ZimVie Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 39.44.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NasdaqGS: ZIMV

ZimVie Inc.

CEO Mr. Vafa Jamali
IPO Date Feb. 16, 2022
Location United States
Headquarters 10225 Westmoor Drive
Employees 2,600
Sector Health Care
Industries
Description

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Similar companies

INGN

Inogen, Inc.

USD 10.62

2.81%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

CVRX

CVRx, Inc.

USD 16.15

7.38%

CNMD

CONMED Corporation

USD 67.79

-2.46%

SIBN

SI-BONE, Inc.

USD 15.70

-3.27%

STE

STERIS plc

USD 207.57

0.10%

SYK

Stryker Corporation

USD 362.80

0.50%

APYX

Apyx Medical Corporation

USD 1.43

-4.03%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

BSX

Boston Scientific Corporation

USD 95.65

1.10%

StockViz Staff

January 15, 2025

Any question? Send us an email